Ann: Positive clinical data reported at breast cancer symposium, page-11

@Duke2, not sure we can say the results were known several months back, because given todays announcement is classified as Market Sensitive, then such results would have been required to be reported when initially obtained. Anyway, at least its a positive result and since success breeds success as the saying goes, then hopefully the results mean clinical trialling will accelerate ( because its now an easier "sell" to prospective candidates for future trials). We might be at a pivot point where an imaging pharma decides it wants an early seat at the table through an equity position... hoping so